Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Company Limited 1652.HK Peers
See (1652.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 1652.HK | HK$0.38 | -3.80% | 288.3M | -1.39 | -HK$0.28 | N/A |
| 3692.HK | HK$30.25 | +3.95% | 176.9B | 37.19 | HK$0.80 | N/A |
| 2196.HK | HK$16.94 | +4.44% | 68.3B | 14.07 | HK$1.20 | +1.78% |
| 0874.HK | HK$17.58 | +1.03% | 43.8B | 9.61 | HK$1.81 | +5.05% |
| 1513.HK | HK$29.80 | +1.53% | 32.8B | 11.73 | HK$2.52 | +4.06% |
| 3320.HK | HK$5.26 | +1.35% | 32.2B | 8.83 | HK$0.58 | +2.87% |
| 0512.HK | HK$8.95 | +3.71% | 30.5B | 12.46 | HK$0.70 | +2.98% |
| 0867.HK | HK$12.20 | +1.67% | 29B | 16.44 | HK$0.73 | +2.43% |
| 3933.HK | HK$15.24 | +2.56% | 27.3B | 9.39 | HK$1.60 | +4.10% |
| 0013.HK | HK$24.90 | +4.84% | 20.5B | 75.97 | HK$0.31 | N/A |
Stock Comparison
1652.HK vs 3692.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 3692.HK has a market cap of 176.9B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 3692.HK trades at HK$30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 3692.HK's P/E ratio is 37.19. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 3692.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 3692.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2196.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2196.HK has a market cap of 68.3B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2196.HK trades at HK$16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2196.HK's P/E ratio is 14.07. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2196.HK's ROE of +0.06%. Regarding short-term risk, 1652.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0874.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0874.HK has a market cap of 43.8B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0874.HK trades at HK$17.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0874.HK's P/E ratio is 9.61. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0874.HK's ROE of +0.07%. Regarding short-term risk, 1652.HK is less volatile compared to 0874.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1513.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1513.HK has a market cap of 32.8B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1513.HK trades at HK$29.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1513.HK's P/E ratio is 11.73. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1513.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 1513.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 3320.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 3320.HK has a market cap of 32.2B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 3320.HK trades at HK$5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 3320.HK's P/E ratio is 8.83. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 3320.HK's ROE of +0.07%. Regarding short-term risk, 1652.HK is less volatile compared to 3320.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0512.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0512.HK has a market cap of 30.5B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0512.HK trades at HK$8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0512.HK's P/E ratio is 12.46. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0512.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 0512.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0867.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0867.HK has a market cap of 29B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0867.HK trades at HK$12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0867.HK's P/E ratio is 16.44. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 1652.HK is less volatile compared to 0867.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 3933.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 3933.HK has a market cap of 27.3B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 3933.HK trades at HK$15.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 3933.HK's P/E ratio is 9.39. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 3933.HK's ROE of +0.19%. Regarding short-term risk, 1652.HK is less volatile compared to 3933.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0013.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0013.HK has a market cap of 20.5B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0013.HK trades at HK$24.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0013.HK's P/E ratio is 75.97. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0013.HK's ROE of -0.01%. Regarding short-term risk, 1652.HK is less volatile compared to 0013.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 9989.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 9989.HK has a market cap of 17.3B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 9989.HK trades at HK$5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 9989.HK's P/E ratio is 11.10. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 9989.HK's ROE of +0.05%. Regarding short-term risk, 1652.HK is less volatile compared to 9989.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1558.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1558.HK has a market cap of 13.1B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1558.HK trades at HK$14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1558.HK's P/E ratio is 24.73. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 1652.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 6600.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 6600.HK has a market cap of 11.8B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 6600.HK trades at HK$18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 6600.HK's P/E ratio is 10.12. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 6600.HK's ROE of +0.36%. Regarding short-term risk, 1652.HK is less volatile compared to 6600.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0570.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0570.HK has a market cap of 11.1B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0570.HK trades at HK$2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0570.HK's P/E ratio is 221.00. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0570.HK's ROE of +0.00%. Regarding short-term risk, 1652.HK is less volatile compared to 0570.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 6185.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 6185.HK has a market cap of 10.5B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 6185.HK trades at HK$34.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 6185.HK's P/E ratio is -20.63. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 6185.HK's ROE of -0.07%. Regarding short-term risk, 1652.HK is less volatile compared to 6185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0460.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0460.HK has a market cap of 10.3B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0460.HK trades at HK$1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0460.HK's P/E ratio is -37.00. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0460.HK's ROE of -0.05%. Regarding short-term risk, 1652.HK is less volatile compared to 0460.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1681.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1681.HK has a market cap of 9.6B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1681.HK trades at HK$11.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1681.HK's P/E ratio is 9.51. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1681.HK's ROE of +0.23%. Regarding short-term risk, 1652.HK is less volatile compared to 1681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0719.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0719.HK has a market cap of 9.1B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0719.HK trades at HK$6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0719.HK's P/E ratio is 9.25. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0719.HK's ROE of +0.09%. Regarding short-term risk, 1652.HK is less volatile compared to 0719.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2005.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2005.HK has a market cap of 8.2B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2005.HK trades at HK$2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2005.HK's P/E ratio is 7.72. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2005.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 2005.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2877.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2877.HK has a market cap of 5.9B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2877.HK trades at HK$8.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2877.HK's P/E ratio is 6.48. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2877.HK's ROE of +0.11%. Regarding short-term risk, 1652.HK is less volatile compared to 2877.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 6896.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 6896.HK has a market cap of 3.2B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 6896.HK trades at HK$4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 6896.HK's P/E ratio is 9.34. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 6896.HK's ROE of +0.23%. Regarding short-term risk, 1652.HK is less volatile compared to 6896.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2633.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2633.HK has a market cap of 3.2B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2633.HK trades at HK$1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2633.HK's P/E ratio is 10.87. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2633.HK's ROE of +0.11%. Regarding short-term risk, 1652.HK is less volatile compared to 2633.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2552.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2552.HK has a market cap of 2.8B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2552.HK trades at HK$3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2552.HK's P/E ratio is -10.48. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2552.HK's ROE of +2.97%. Regarding short-term risk, 1652.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2161.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2161.HK has a market cap of 2.7B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2161.HK trades at HK$3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2161.HK's P/E ratio is 13.96. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2161.HK's ROE of +0.17%. Regarding short-term risk, 1652.HK is less volatile compared to 2161.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1061.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1061.HK has a market cap of 2.5B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1061.HK trades at HK$4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1061.HK's P/E ratio is 8.32. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1061.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 2348.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 2348.HK has a market cap of 1.9B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 2348.HK trades at HK$1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 2348.HK's P/E ratio is 3.02. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 2348.HK's ROE of +0.17%. Regarding short-term risk, 1652.HK and 2348.HK have similar daily volatility (0.00).
1652.HK vs 8049.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 8049.HK has a market cap of 1.2B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 8049.HK trades at HK$2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 8049.HK's P/E ratio is 5.81. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 8049.HK's ROE of +0.08%. Regarding short-term risk, 1652.HK is less volatile compared to 8049.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1349.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1349.HK has a market cap of 1.1B. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1349.HK trades at HK$3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1349.HK's P/E ratio is 81.25. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1349.HK's ROE of +0.02%. Regarding short-term risk, 1652.HK is less volatile compared to 1349.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 3839.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 3839.HK has a market cap of 883.4M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 3839.HK trades at HK$3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 3839.HK's P/E ratio is 10.49. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 3839.HK's ROE of +0.05%. Regarding short-term risk, 1652.HK is less volatile compared to 3839.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0950.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0950.HK has a market cap of 847.9M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0950.HK trades at HK$1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0950.HK's P/E ratio is 9.00. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0950.HK's ROE of +0.06%. Regarding short-term risk, 1652.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0239.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0239.HK has a market cap of 785.3M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0239.HK trades at HK$2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0239.HK's P/E ratio is 10.08. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0239.HK's ROE of +0.11%. Regarding short-term risk, 1652.HK and 0239.HK have similar daily volatility (0.00).
1652.HK vs 0503.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 1652.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 3737.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 3737.HK has a market cap of 742.5M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 3737.HK trades at HK$0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 3737.HK's P/E ratio is 7.33. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 3737.HK's ROE of +0.09%. Regarding short-term risk, 1652.HK is less volatile compared to 3737.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0897.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0897.HK has a market cap of 388.2M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0897.HK trades at HK$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0897.HK's P/E ratio is -34.50. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0897.HK's ROE of +0.00%. Regarding short-term risk, 1652.HK is less volatile compared to 0897.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 8329.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 8329.HK has a market cap of 297M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 8329.HK trades at HK$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 8329.HK's P/E ratio is 8.85. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 8329.HK's ROE of +0.03%. Regarding short-term risk, 1652.HK is less volatile compared to 8329.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0455.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0455.HK has a market cap of 290.3M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0455.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0455.HK's P/E ratio is -4.50. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 0455.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1011.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1011.HK has a market cap of 283.2M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1011.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1011.HK's P/E ratio is -1.91. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1011.HK's ROE of +0.14%. Regarding short-term risk, 1652.HK is less volatile compared to 1011.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0858.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0858.HK has a market cap of 200.8M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0858.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0858.HK's P/E ratio is 1.20. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0858.HK's ROE of +0.15%. Regarding short-term risk, 1652.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 8622.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 8622.HK has a market cap of 197.7M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 8622.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 8622.HK's P/E ratio is -39.50. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 8622.HK's ROE of -0.08%. Regarding short-term risk, 1652.HK is less volatile compared to 8622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1498.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1498.HK has a market cap of 193.6M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1498.HK trades at HK$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1498.HK's P/E ratio is -5.44. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1498.HK's ROE of -0.29%. Regarding short-term risk, 1652.HK is less volatile compared to 1498.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 1312.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 1312.HK has a market cap of 156.2M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 1312.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 1312.HK's P/E ratio is -2.80. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 1312.HK's ROE of -0.07%. Regarding short-term risk, 1652.HK is less volatile compared to 1312.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1652.HK.
1652.HK vs 0911.HK Comparison
1652.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 1652.HK stands at 288.3M. In comparison, 0911.HK has a market cap of 40.7M. Regarding current trading prices, 1652.HK is priced at HK$0.38, while 0911.HK trades at HK$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
1652.HK currently has a P/E ratio of -1.39, whereas 0911.HK's P/E ratio is 24.00. In terms of profitability, 1652.HK's ROE is -0.42%, compared to 0911.HK's ROE of +0.00%. Regarding short-term risk, 1652.HK and 0911.HK have similar daily volatility (0.00).